A Study of the Safety and Effectiveness of Irosustat When Added to an AI in ER+ve Locally Advanced or Metastatic Breast Cancer.
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Locally Advanced Breast Cancer|Metastatic Breast Cancer
Interventions: DRUG: Irosustat
Sponsor: Imperial College London
Collaborators: Cancer Research UK